Abstract
Rationale
3,4-methylenedioxymethamphetamine (MDMA, ecstasy) produces an acute release of 5-HT in the brain, together with increased locomotion and hyperthermia.
Objective
This study examined whether the acute functional changes of locomotor activity and body temperature are related to enhanced 5-HT release induced by MDMA.
Methods
We concomitantly measured changes in extraneuronal 5-HT by in vivo brain microdialysis and used radiotelemetry to measure locomotion and body temperature to establish whether any positive correlations occur between these three parameters. ‘Binge-type’ repeated administration of low doses of MDMA (3 and 6 mg/kg given at 2-h intervals three times) were given to provide drug exposure similar to that experienced by recreational drug users.
Results
MDMA induced acute hyperactivity, changes in core body temperature (both hypothermia and hyperthermia) and elevation of hippocampal 5-HT overflow, all of which were dependent on the dose of MDMA administered. The change in locomotor activity and the magnitude of the hyperthermia appeared to be unrelated both to each other and to the magnitude of MDMA-induced 5-HT release. The study also found evidence of long-term disruption of novel object discrimination 2 weeks following “binge-type” repeated MDMA administration.
Conclusions
MDMA-induced 5-HT release in the brain was not responsible for either the hyperthermia or increased locomotor activity that occurred. Since neither dose schedule of MDMA induced a neurotoxic loss of brain 5-HT 2 weeks after its administration, the impairment of recognition memory found in novel object discrimination probably results from other long-term changes yet to be established.
Similar content being viewed by others
References
Able JA, Gudelsky GA, Vorhees CV, Williams MT (2006) 3, 4-Methylenedioxymethamphetamine in adult rats produces deficits in path integration and spatial reference memory. Biol Psychiatry 59:1219–1226
Bankson MG, Cunningham KA (2002) Pharmacological studies of the acute effects of (+)-3, 4-methylenedioxymethamphetamine on locomotor activity: role of 5-HT(1B/1D) and 5-HT(2) receptors. Neuropsychopharmacology 26:40–52
Baumann MH, Clark RD, Franken FH, Rutter JJ, Rothman RB (2008a) Tolerance to 3, 4-methylenedioxymethamphetamine in rats exposed to single high-dose binges. Neuroscience 152:773–784
Baumann MH, Clark RD, Rothman RB (2008b) Locomotor stimulation produced by 3, 4-methylenedioxymethamphetamine (MDMA) is correlated with dialysate levels of serotonin and dopamine in rat brain. Pharmacol Biochem Behav 90:208–217
Benamar K, Geller EB, Adler MW (2008) A new brain area affected by 3, 4-methylenedioxymethamphetamine: a microdialysis-biotelemetry study. Eur J Pharmacol 596:84–88
Bianchi M, Fone KCF, Azmi N, Heidbreder CA, Hagan JJ, Marsden CA (2006) Isolation rearing induces recognition memory deficits accompanied by cytoskeletal alterations in rat hippocampus. Eur J Neurosci 24:2894–2902
Broening HW, Morford LL, Inman-Wood SL, Fukumura M, Vorhees CV (2001) 3, 4-methylenedioxymethamphetamine (ecstasy)-induced learning and memory impairments depend on the age of exposure during early development. J Neurosci 21:3228–3235
Bull EJ, Hutson PH, Fone KCF (2004) Decreased social behaviour following 3, 4-methylenedioxymethamphetamine (MDMA) is accompanied by changes in 5-HT2A receptor responsivity. Neuropharmacology 46:202–210
Bull EJ, Porkess V, Rigby M, Hutson PH, Fone KC (2006) Pre-treatment with 3, 4-methylenedioxymethamphetamine (MDMA) causes long-lasting changes in 5-HT2A receptor-mediated glucose utilization in the rat brain. J Psychopharmacol 20:272–280
Callaway CW, Wing LL, Geyer MA (1990) Serotonin release contributes to the locomotorstimulant effects of 3, 4-methylenedioxymethamphetamine in rats. J Pharmacol Exp Ther 254:456–464
Capela JP, Carmo H, Remiao F, Bastos ML, Meisel A, Carvalho F (2009) Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview. Mol Neurobiol 39:210–271
Chance M (1947) Aggregation as a factor influencing the toxicity of sympathomimetic amines in mice. J Pharmacol Exp Ther 87:214–219
Che S, Johnson M, Hanson GR, Gibb JW (1995) Body temperature effect on methylenedioxymethamphetamine-induced acute decrease in tryptophan hydroxylase activity. Eur J Pharmacol 293:447–453
Dafters RI (1994) Effect of ambient temperature on hyperthermia and hyperkinesis induced by 3, 4-methylenedioxymethamphetamine (MDMA or "ecstasy") in rats. Psychopharmacology 114:505–508
Dafters RI (1995) Hyperthermia following MDMA administration in rats: effects of ambient temperature, water consumption, and chronic dosing. Physiol Behav 58:877–882
Docherty JD, Green AR (2010). The role of monoamines in the changes in body temperature induced by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and derivatives. Br J Pharmacol (in press).
Ennaceur A, Delacour J (1988) A new one-trial test for neurobiological studies of memory in rats. 1: behavioral data. Behav Brain Res 31:47–59
Esteban B, O’shea E, Camarero J, Sanchez V, Green AR, Colado MI (2001) 3, 4-methylenedioxymethamphetamine induces monoamine release but not toxicity when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose. Psychopharmacology 154:251–260
Fantegrossi WE, Godlewski T, Karabenick RL, Stephens JM, Ullrich T, Rice KC et al (2003) Pharmacological characterization of the effects of 3, 4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice. Psychopharmacology 166:202–211
Fone KCF, Beckett SR, Topham IA, Swettenham J, Ball M, Maddocks L (2002) Long-term changes in social interaction and reward following repeated MDMA administration to adolescent rats without accompanying serotonergic neurotoxicity. Psychopharmacology 159:437–444
Freedman RR, Johanson CE, Tancer ME (2005) Thermoregulatory effects of 3, 4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology 183:248–256
Goñi-Allo B, Mathúna BÓ, Segura M, Puerta E, Lasheras B, de la Torre R, Aguirre N (2008) The relationship between core body temperature and 3, 4-methylenedioxymethamphetamine metabolism in rats: implications for neurotoxicity. Psychopharmacology 197:263–278
Gouzoulis-Mayfrank E, Daumann J, Tuchtenhagen F, Pelz S, Becker S, Kunert HJ et al (2000) Impaired cognitive performance in drug free users of recreational ecstasy (MDMA). J Neurol Neurosurg Psychiatry 68:719–725
Green AR, Mechan AO, Elliott JM, O’shea E, Colado MI (2003) The pharmacology and clinical pharmacology of 3, 4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol Rev 55:463–508
Green AR, Sanchez V, O’shea E, Saadat KS, Elliott JM, Colado MI (2004) Effect of ambient temperature and a prior neurotoxic dose of 3, 4-methylenedioxymethamphetamine (MDMA) on the hyperthermic response of rats to a single or repeated ('binge' ingestion) low dose of MDMA. Psychopharmacology 173:264–269
Green AR, O’shea E, Saadat KS, Elliott JM, Colado MI (2005) Studies on the effect of MDMA (‘ecstasy’) on the body temperature of rats housed at different ambient room temperatures. Br J Pharmacol 146:306–312
Green AR, Gabrielsson J, Marsden CA, Fone KCF (2009) MDMA: On the translation from rodent to human dosing. Psychopharmacology 204:375–378
Hammersley R, Ditton J, Smith I, Short E (1999) Patterns of ecstasy use by drug users. Br J Criminol 39:625–647
Irvine RJ, Keane M, Felgate P, McCann UD, Callaghan PD, White JM (2006) Plasma drug concentrations and physiological measures in ‘dance party’ participants. Neuropsychopharmacology 31:424–430
Johnson M, Mitros K, Stone DM, Zobrist R, Hanson GR, Gibb JW (1992) Effect of flunarizine and nimodipine on the decrease in tryptophan hydroxylase activity induced by methamphetamine and 3, 4-methylenedioxymethamphetamine. J Pharmacol Exp Ther 261:586–591
Kindlundh-Hogberg AM, Schioth HB, Svenningsson P (2007) Repeated intermittent MDMA binges reduce DAT density in mice and SERT density in rats in reward regions of the adolescent brain. Neurotoxicology 28:1158–1169
King MV, Sleight AJ, Woolley ML, Topham IA, Marsden CA, Fone KCF (2004) 5-HT6 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing consolidation–an effect sensitive to NMDA receptor antagonism. Neuropharmacology 47:195–204
King MV, Spicer C, Sleight AJ, Marsden CA, Fone KCF (2009) Impact of regional 5-HT depletion on the cognitive enhancing effects of a typical 5-ht(6) receptor antagonist, Ro 04-6790, in the Novel Object Discrimination task. Psychopharmacology 202:111–123
Malberg JE, Seiden LS (1998) Small changes in ambient temperature cause large changes in 3, 4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat. J Neurosci 18:5086–5094
Marston HM, Reid ME, Lawrence JA, Olverman HJ, Butcher SP (1999) Behavioural analysis of the acute and chronic effects of MDMA treatment in the rat. Psychopharmacology 144:67–76
McGregor IS, Gurtman CG, Morley KC, Clemens KJ, Blokland A, Li KM et al (2003) Increased anxiety and "depressive" symptoms months after MDMA ("ecstasy") in rats: drug-induced hyperthermia does not predict long-term outcomes. Psychopharmacology 168:465–474
Mechan AO, Esteban B, O’shea E, Elliott JM, Colado MI, Green AR (2002) The pharmacology of the acute hyperthermic response that follows administration of 3, 4-methylenedioxymethamphetamine (MDMA, ‘ecstasy’) to rats. Br J Pharmacol 135:170–180
Morley KC, Gallate JE, Hunt GE, Mallet PE, McGregor IS (2001) Increased anxiety and impaired memory in rats 3 months after administration of 3, 4-methylenedioxymethamphetamine ("ecstasy"). Eur J Pharmacol 433:91–99
Morton AJ, Hickey MA, Dean LC (2001) Methamphetamine toxicity in mice is potentiated by exposure to loud music. NeuroReport 12:3277–3281
O’Shea E, Granados R, Esteban B, Colado MI, Green AR (1998) The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA (‘ecstasy’). Neuropharmacology 37:919–926
O’Shea E, Escobedo I, Orio L, Sanchez V, Navarro M, Green AR et al (2005) Elevation of ambient room temperature has differential effects on MDMA-induced 5-HT and dopamine release in striatum and nucleus accumbens of rats. Neuropsychopharmacology 30:1312–1323
O’Shea E, Orio L, Escobedo I, Sanchez V, Camarero J, Green AR et al (2006) MDMA-induced neurotoxicity: long-term effects on 5-HT biosynthesis and the influence of ambient temperature. Br J Pharmacol 148:778–785
Parrott AC (2005) Chronic tolerance to recreational MDMA (3, 4-methylenedioxymethamphetamine) or Ecstasy. J Psychopharmacol 19:71–83
Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates, 4th edition, 4th edn. Academic, London
Piper BJ, Meyer JS (2004) Memory deficit and reduced anxiety in young adult rats given repeated intermittent MDMA treatment during the periadolescent period. Pharmacol Biochem Behav 79:723–731
Skelton MR, Able JA, Grace CE, Herring NR, Schaefer TL, Gudelsky GA et al (2008) (+/−)-3, 4-Methylenedioxymethamphetamine treatment in adult rats impairs path integration learning: a comparison of single vs once per week treatment for 5 weeks. Neuropharmacology 55:1121–1130
Sprague JE, Preston AS, Leifheit M, Woodside B (2003) Hippocampal serotonergic damage induced by MDMA (ecstasy): effects on spatial learning. Physiol Behav 79:281–287
Stanley N, Salem A, Irvine RJ (2007) The effects of co-administration of 3, 4-methylenedioxymethamphetamine (“ecstasy”) or para-methoxyamphetamine and moclobemide at elevated ambient temperatures on striatal 5-HT, body temperature and behavior in rats. Neuroscience 146:321–329
Starr MA, Page ME, Waterhouse BD (2008) MDMA (3,4 methylene-dioxymethamphetamine)-mediated distortion of somatosensory signal transmission and neurotransmitter efflux in the ventral posteriormedial thalamus. J Pharmacol Exp Ther 327:20–31
Stone DM, Merchant KM, Hanson GR, Gibb JW (1987) Immediate and long-term effects of 3, 4-methylenedioxymethamphetamine on serotonin pathways in brain of rat. Neuropharmacology 26:1677–1683
Topp L, Hando J, Dillon P, Roche A, Solowij N (1999) Ecstasy use in Australia: patterns of use and associated harm. Drug Alcohol Depend 55:105–115
Tucker GT, Lennard MS, Ellis SW, Woods HF, Cho AK, Lin LY et al (1994) The demethylenation of methylenedioxymethamphetamine (“ecstasy”) by debrisoquine hydroxylase (CYP2D6). Biochem Pharmacol 47:1151–1156
Von Huben SN, Lay CC, Crean RD, Davis SA, Katner SN, Taffe MA (2007) Impact of ambient temperature on hyperthermia induced by (+/−)3, 4-methylenedioxymethamphetamine in rhesus macaques. Neuropsychopharmacology 32:673–681
Winstock AR, Griffiths P, Stewart D (2001) Drugs and the dance music scene: a survey of current drug use patterns among a sample of dance music enthusiasts in the UK. Drug Alcohol Depend 64:9–17
Yang JS, Jamei M, Heydari A, Yeo KR, de la Torre R, Farre M et al (2006) Implications of mechanism-based inhibition of CYP2D6 for the pharmacokinetics and toxicity of MDMA. J Psychopharmacol 20:842–849
Yehuda S, Wurtman RJ (1972a) Effects of d-amphetamine and related drugs on colonic temperatures of rats kept at various ambient temperatures. Life Sci Physiol Pharmacol 11:851–859
Yehuda S, Wurtman RJ (1972b) Release of brain dopamine as probable mechanism for hypothermic effect of d-amphetamine. Nature 240:477–478
Acknowledgements
We are grateful for the Thai Royal Government for funding RR and acknowledge the assistance of Ian Topham with behavioural studies and Fran Ebling for advice on radiotelemetry.
Conflict of interest
The authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rodsiri, R., Spicer, C., Green, A.R. et al. Acute concomitant effects of MDMA binge dosing on extracellular 5-HT, locomotion and body temperature and the long-term effect on novel object discrimination in rats. Psychopharmacology 213, 365–376 (2011). https://doi.org/10.1007/s00213-010-1921-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-010-1921-9